Chugai – Talk Bio

FDA Rejects Sydnexis Myopia Drug for Kids; Chugai to Buy Renalys for $98M Upfront

3 days ago talkbio0Tagged Chugai, Complete Response Letter, methionine, Myopia, Ophthalmology specialty, Pediatric brand name, Renalys, SYD-101, Sydnexis, United States Food and Drug Administration

FDA; SYD-101; Sydnexis; myopia; pediatric; complete response letter; Chugai; Renalys; acquisition; $98M; ophthalmology

Rani Therapeutics Appoints Abe Bassan and Vasudev Bailey to Board of Directors

3 days ago talkbio0Tagged Abe Bassan, Anomaly Ventures, BioCapital, Biological Factors, biotherapeutics, Board change, board of directors, Chugai, Collaboration, Obstetric Delivery, Oral cavity, Rani Therapeutics, Samsara, Vasudev Bailey

Rani Therapeutics; Board of Directors; Abe Bassan; Vasudev Bailey; biotherapeutics; oral biologics delivery; Samsara BioCapital; Anomaly Ventures; Chugai collaboration; Board change

Roche’s Chugai Enters $780M Deal with Swiss ADC Specialist Araris Biotech

10 months ago talkbio0Tagged Antibody-Drug Conjugates, Araris, biotech, Chugai, Roche (company), therapeutic autologous dendritic cells

Roche, Chugai, Araris Biotech, ADC, Antibody-Drug Conjugate, Biotech Deal